dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate

C60H68BBrF6K2N12O9 — CID 162263967

IUPACdipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
SMILESC.CN1Cc2c(-c3cccc4nc(-c5cnn(C)c5)c(C(F)F)cc34)nc(C3CCOCC3)n2C(F)C1=O.CN1Cc2c(Br)nc(C3CCOCC3)n2C(F)C1=O.Cn1cc(-c2nc3cccc(B4OC(C)(C)C(C)(C)O4)c3cc2C(F)F)cn1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H25F3N6O2.C20H22BF2N3O2.C12H15BrFN3O2.CH2O3.CH4.2K.H/c1-33-13-20-22(32-25(14-6-8-37-9-7-14)35(20)24(29)26(33)36)16-4-3-5-19-17(16)10-18(23(27)28)21(31-19)15-11-30-34(2)12-15;1-19(2)20(3,4)28-21(27-19)15-7-6-8-16-13(15)9-14(18(22)23)17(25-16)12-10-24-26(5)11-12;1-16-6-8-9(13)15-11(7-2-4-19-5-3-7)17(8)10(14)12(16)18;2-1-4-3;;;;/h3-5,10-12,14,23-24H,6-9,13H2,1-2H3;6-11,18H,1-5H3;7,10H,2-6H2,1H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
InChIKeyAZNFZIZUACREDT-UHFFFAOYSA-M
MW1384.18 g/mol
LogP3.81
Rot. Bonds9

About dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate

dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate (PubChem CID 162263967) has the molecular formula C60H68BBrF6K2N12O9 and a molecular weight of 1384.18 g/mol. Its IUPAC name is dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate.

Molecular Properties

Compound Namedipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
PubChem CID162263967
Molecular FormulaC60H68BBrF6K2N12O9
Molecular Weight1384.18 g/mol
Exact Mass1382.37
IUPAC Namedipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
SMILESC.CN1Cc2c(-c3cccc4nc(-c5cnn(C)c5)c(C(F)F)cc34)nc(C3CCOCC3)n2C(F)C1=O.CN1Cc2c(Br)nc(C3CCOCC3)n2C(F)C1=O.Cn1cc(-c2nc3cccc(B4OC(C)(C)C(C)(C)O4)c3cc2C(F)F)cn1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H25F3N6O2.C20H22BF2N3O2.C12H15BrFN3O2.CH2O3.CH4.2K.H/c1-33-13-20-22(32-25(14-6-8-37-9-7-14)35(20)24(29)26(33)36)16-4-3-5-19-17(16)10-18(23(27)28)21(31-19)15-11-30-34(2)12-15;1-19(2)20(3,4)28-21(27-19)15-7-6-8-16-13(15)9-14(18(22)23)17(25-16)12-10-24-26(5)11-12;1-16-6-8-9(13)15-11(7-2-4-19-5-3-7)17(8)10(14)12(16)18;2-1-4-3;;;;/h3-5,10-12,14,23-24H,6-9,13H2,1-2H3;6-11,18H,1-5H3;7,10H,2-6H2,1H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
InChIKeyAZNFZIZUACREDT-UHFFFAOYSA-M
XLogP3.81
TPSA223.96 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds9
Heavy Atoms91
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001384.18
LogP ≤ 53.81
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
The IUPAC name of dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate (CID 162263967) is dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate.
What is the SMILES notation for dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
The canonical SMILES for dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate is C.CN1Cc2c(-c3cccc4nc(-c5cnn(C)c5)c(C(F)F)cc34)nc(C3CCOCC3)n2C(F)C1=O.CN1Cc2c(Br)nc(C3CCOCC3)n2C(F)C1=O.Cn1cc(-c2nc3cccc(B4OC(C)(C)C(C)(C)O4)c3cc2C(F)F)cn1.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
The InChIKey is AZNFZIZUACREDT-UHFFFAOYSA-M. The full InChI is InChI=1S/C26H25F3N6O2.C20H22BF2N3O2.C12H15BrFN3O2.CH2O3.CH4.2K.H/c1-33-13-20-22(32-25(14-6-8-37-9-7-14)35(20)24(29)26(33)36)16-4-3-5-19-17(16)10-18(23(27)28)21(31-19)15-11-30-34(2)12-15;1-19(2)20(3,4)28-21(27-19)15-7-6-8-16-13(15)9-14(18(22)23)17(25-16)12-10-24-26(5)11-12;1-16-6-8-9(13)15-11(7-2-4-19-5-3-7)17(8)10(14)12(16)18;2-1-4-3;;;;/h3-5,10-12,14,23-24H,6-9,13H2,1-2H3;6-11,18H,1-5H3;7,10H,2-6H2,1H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate has a molecular weight of 1384.18 g/mol, XLogP of 3.81, 9 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-bromo-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5-fluoro-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate is sourced from PubChem (CID 162263967), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).